Fernando Reinach - Amyris Independent Director
| AMRSDelisted Stock | USD 0.04 0 8.64% |
Director
Dr. Fernando de Castro Reinach, Ph.D., is Independent Director of Amyris, Inc. Dr. Reinach was a managing partner of Pitanga Fund, a VC fund based in Brazil, since May 2011. From 2001 to May 2010, Dr. Reinach was a general partner at Votorantim Novos Negcios Ltda. Before joining Votorantim, he was involved in the creation of two companies, Genomic Engenharia Molecular Ltda., a molecular diagnostic laboratory, and .ComDominio SA, a datacenter company. Dr. Reinach holds a BS degree in biology from the University of So Paulo and a Doctor of Philosophy degree in Cell and Molecular Biology from Cornell University Medical College. Dr. Reinachs experience with Brazilian business practices enables him to provide important insight and guidance to our management team and Board and to assist management with establishing and developing operations in Brazil. since 2008.
| Age | 59 |
| Tenure | 16 years |
| Professional Marks | Ph.D |
| Phone | 510 450 0761 |
| Web | https://amyris.com |
Amyris Management Efficiency
The company has return on total asset (ROA) of (0.464) % which means that it has lost $0.464 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (5.3208) %, meaning that it created substantial loss on money invested by shareholders. Amyris' management efficiency ratios could be used to measure how well Amyris manages its routine affairs as well as how well it operates its assets and liabilities.The company currently holds 981.55 M in liabilities with Debt to Equity (D/E) ratio of 1.62, which is about average as compared to similar companies. Amyris Inc has a current ratio of 0.86, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Amyris until it has trouble settling it off, either with new capital or with free cash flow. So, Amyris' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Amyris Inc sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Amyris to invest in growth at high rates of return. When we think about Amyris' use of debt, we should always consider it together with cash and equity.
Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Carrie McKim | Codexis | N/A | |
| Pam Cheng | Codexis | 47 | |
| Marshall Mohr | Pacific Biosciences of | 62 | |
| William Baum | Gevo Inc | 71 | |
| Steven Hutcheson | Aemetis | 63 | |
| Dennis Wolf | Codexis | 65 | |
| Kathy Ordonez | Pacific Biosciences of | 67 | |
| Gary Mize | Gevo Inc | 67 | |
| Christian Henry | Pacific Biosciences of | 50 | |
| Harold Sorgenti | Aemetis | 80 | |
| William Ericson | Pacific Biosciences of | 59 | |
| Lucy Shapiro | Pacific Biosciences of | 77 | |
| Francis Barton | Aemetis | 69 | |
| Brook Byers | Pacific Biosciences of | 70 | |
| Randall Livingston | Pacific Biosciences of | 64 | |
| Randy Livingston | Pacific Biosciences of | 60 | |
| Ruth Dreessen | Gevo Inc | 61 | |
| Bernard Kelley | Codexis | 76 | |
| Byron Dorgan | Codexis | 75 | |
| John Milligan | Pacific Biosciences of | 57 | |
| Patrick Yang | Codexis | 70 | |
Management Performance
| Return On Equity | -5.32 | |||
| Return On Asset | -0.46 |
Amyris Inc Leadership Team
Elected by the shareholders, the Amyris' board of directors comprises two types of representatives: Amyris inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Amyris. The board's role is to monitor Amyris' management team and ensure that shareholders' interests are well served. Amyris' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Amyris' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Raymond Williams, Independent Director | ||
| Karen Weaver, Principal Accounting Officer, Vice President - Finance | ||
| Peter Denardo, Director of Investor Relations and Corporate Communications | ||
| Lisa Qi, Director | ||
| Patrick Yang, Director | ||
| Philippe Boisseau, Director | ||
| Caroline Hadfield, Pres Aprinnova | ||
| Margaret Georgiadis, Director | ||
| Kathleen Valiasek, CFO | ||
| Jonathan Wolter, Interim CFO | ||
| Anthony Hughes, Chief Accounting Officer | ||
| Karen Rohde, Chief Human Resources Officer | ||
| Tina Maloney, Chief Accounting Officer | ||
| Christophe Vuillez, Director | ||
| Nicole Kelsey, Chief Sec | ||
| Oreste Fieschi, President of Sweeteners and Ingredients | ||
| Raffi Asadorian, CFO | ||
| Carole Piwnica, Independent Director | ||
| Eduardo Alvarez, Chief Officer | ||
| James McCann, Director | ||
| Hermanus Kieftenbeld, CFO Officer | ||
| Christine Ofori, Chief Officer | ||
| John Melo, CEO and President and Director | ||
| Philip Eykerman, Director | ||
| Abdullah Thani, Independent Director | ||
| Christoph Goppelsroeder, Director | ||
| Charles Kraft, VP Devel | ||
| Neil Williams, Independent Director | ||
| Fernando Reinach, Independent Director | ||
| Abraham Klaeijsen, Director | ||
| Elizabeth CPA, Chief Controller | ||
| Geoffrey Duyk, Independent Director | ||
| Nicholas Khadder, Sr. VP, General Counsel and Corporate Secretary | ||
| Joel Cherry, President of RandD | ||
| Frank Kung, Director | ||
| Chris Jaenike, Interim General Counsel | ||
| Jim Iacoponi, VP Ingredients | ||
| John Doerr, Independent Director | ||
| Steven Mills, Director |
Amyris Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Amyris a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -5.32 | |||
| Return On Asset | -0.46 | |||
| Profit Margin | (2.29) % | |||
| Operating Margin | (2.18) % | |||
| Current Valuation | 1.06 B | |||
| Shares Outstanding | 369.39 M | |||
| Shares Owned By Insiders | 5.86 % | |||
| Shares Owned By Institutions | 54.12 % | |||
| Number Of Shares Shorted | 64.2 M | |||
| Price To Earning | (0.51) X |
Pair Trading with Amyris
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Amyris position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Amyris will appreciate offsetting losses from the drop in the long position's value.Moving against Amyris Stock
| 0.91 | CHKEZ | Chesapeake Energy | PairCorr |
| 0.91 | CHKEL | Chesapeake Energy | PairCorr |
| 0.8 | MAPSW | WM Technology | PairCorr |
| 0.66 | GCMGW | GCM Grosvenor | PairCorr |
| 0.64 | ATCOL | Atlas Corp | PairCorr |
The ability to find closely correlated positions to Amyris could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Amyris when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Amyris - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Amyris Inc to buy it.
The correlation of Amyris is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Amyris moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Amyris Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Amyris can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Other Consideration for investing in Amyris Stock
If you are still planning to invest in Amyris Inc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Amyris' history and understand the potential risks before investing.
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |